NASALCROM Drug Patent Profile
✉ Email this page to a colleague
When do Nasalcrom patents expire, and when can generic versions of Nasalcrom launch?
Nasalcrom is a drug marketed by Blacksmith Brands and is included in one NDA.
The generic ingredient in NASALCROM is cromolyn sodium. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nasalcrom
A generic version of NASALCROM was approved as cromolyn sodium by SANDOZ on June 16th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NASALCROM?
- What are the global sales for NASALCROM?
- What is Average Wholesale Price for NASALCROM?
Summary for NASALCROM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 98 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,783 |
| DailyMed Link: | NASALCROM at DailyMed |
Recent Clinical Trials for NASALCROM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vishwajit Nimgaonkar, MD PhD | Phase 1/Phase 2 |
| Stanley Medical Research Institute | Phase 1/Phase 2 |
| Wolfson Medical Center | Phase 3 |
US Patents and Regulatory Information for NASALCROM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blacksmith Brands | NASALCROM | cromolyn sodium | SPRAY, METERED;NASAL | 020463-001 | Jan 3, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
